Sign in

KEQU on Nasdaq

KEWAUNEE SCIENTIFIC CORP /DE/

KEWAUNEE SCIENTIFIC CORP /DE/ is an American laboratory apparatus and furniture company based in Dover.2 Its shares trade on Nasdaq under the symbol KEQU.2

Price unavailable

Last updated Oct 21, 2026.

Overview

$282.0MRevenue, fiscal 20263
$9.6MNet income, fiscal 20263

Compare with REFLECT SCIENTIFIC, INC., or pick any stock.

  • TickerKEQU on Nasdaq2
  • IndustryLaboratory Apparatus & Furniture2
  • HeadquartersDover, United States2
  • Incorporated inDE4
  • Business address2700 W Front St, Statesville, Nc 286774
  • Filer categoryNon-accelerated filer, Smaller reporting company4
  • Legal formCorporation2
  • LEI549300Z8MHH8NUYXQ2292
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O NATIONAL REGISTERED AGENTS, INC., 19904 Dover, United States2
  • Registered withDivision of Corporations, Department of State, 7545172

See how the biggest companies compare on our leaderboards

Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Our acquisition of Nu Aire, Inc., ("Nu Aire"), completed in November 2024, complements the Company's portfolio through Nu Aire's biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products. Nu Aire is renowned for its manufacturing of biological safety cabinets, airflow products, CO2 incubators, ultralow freezers, animal handling eq…5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

28.5%Gross margin3
5.9%Operating margin3
3.4%Net margin3
17.3%Revenue growth, 20263
12.9%Return on equity3
0.20×Debt to equity3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

"Laboratory Products Group (""LPG"") [Member]" brought in 76% of the revenue KEWAUNEE SCIENTIFIC CORP /DE/ broke down this way in fiscal 2026.

  1. "Laboratory Products Group (""LPG"") [Member]"$214.9M376%up 20% from 2025
  2. International Operations$67.1M324%up 10% from 2025
Business segments by year
Business segments20252026
"Laboratory Products Group (""LPG"") [Member]"$179.4M$214.9M
International Operations$61.1M$67.1M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue71¢$201.6M
  • Research and development0¢$898.0K
  • Other costs24¢$66.7M
  • Income tax1¢$3.3M
  • Profit3¢$9.6M

Out of $282.0M in revenue.3

Where each dollar of operating cash went, fiscal 2026

  • Kept or used elsewhere100¢$18.6M

Out of $18.6M of cash from operations.3

Financial statements

Revenue678910113$282.0M in 2026+92% since 2019
0$100.0M$200.0M$300.0M2019: $146.6M$146.6M20192020: $147.5M$147.5M2020+1%2021: $147.5M$147.5M2021−0%2022: $168.9M$168.9M2022+15%2023: $219.5M$219.5M2023+30%2024: $203.8M$203.8M2024−7%2025: $240.5M$240.5M2025+18%2026: $282.0M$282.0M2026+17%
Gross profit678910113$80.4M in 2026+218% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $25.3M$25.3M20192020: $23.4M$23.4M2020−7%2021: $24.0M$24.0M2021+2%2022: $24.2M$24.2M2022+1%2023: $35.6M$35.6M2023+47%2024: $52.1M$52.1M2024+46%2025: $68.9M$68.9M2025+32%2026: $80.4M$80.4M2026+17%
Operating income678910113$16.7M in 2026+691% since 2019
-$10.0M0$10.0M$20.0M2019: $2.1M$2.1M20192020: -$2.3M-$2.3M20202021: -$1.3M-$1.3M2021−44%2022: -$2.6M-$2.6M2022+98%2023: $5.4M$5.4M20232024: $18.3M$18.3M2024+241%2025: $17.8M$17.8M2025−3%2026: $16.7M$16.7M2026−6%
Net income678910113$9.6M in 2026+529% since 2019
-$10.0M0$10.0M$20.0M2019: $1.5M$1.5M20192020: -$4.7M-$4.7M20202021: -$3.7M-$3.7M2021−22%2022: -$6.1M-$6.1M2022+67%2023: $738.0K$738.0K20232024: $18.8M$18.8M2024+2441%2025: $11.4M$11.4M2025−39%2026: $9.6M$9.6M2026−16%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2026-04-302025-04-30
Net sales$282.0M$240.5M
Cost of products sold$201.6M$171.6M
Gross profit$80.4M$68.9M
Operating expenses$63.7M$51.1M
Operating earnings$16.7M$17.8M
Other income, net$880.0K$240.0K
Interest expense-$3.9M-$3.2M
Total earnings before income tax expense$13.7M$14.8M
Income tax expense$3.3M$3.2M
Net earnings$10.5M$11.6M
Less: net earnings attributable to the non-controlling interest$847.0K$178.0K
Net earnings attributable to Kewaunee Scientific Corporation$9.6M$11.4M
Basic (in usd per share)$3.36$3.98
Diluted (in usd per share)$3.22$3.83
Basic (in shares)2.9M shares2.9M shares
Diluted (in shares)3.0M shares3.0M shares

Compare KEWAUNEE SCIENTIFIC CORP /DE/ with another company

Corporate structure

KEWAUNEE SCIENTIFIC CORP /DE/ sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of KEWAUNEE SCIENTIFIC CORP /DE/

  • Minerva Advisors LLC Filed SCHEDULE 13G/A on KEWAUNEE SCIENTIFIC CORP /DE/, latest Jun 29, 2026 (5 filings since Feb 14, 2022)
  • Northern Trust Filed SCHEDULE 13G/A on KEWAUNEE SCIENTIFIC CORP /DE/, latest Feb 17, 2026 (4 filings since Feb 8, 2022)
  • Anita G. Zucker Filed SCHEDULE 13D/A on KEWAUNEE SCIENTIFIC CORP /DE/, latest Feb 5, 2025 (2 filings since Mar 10, 2023)
  • DIMENSIONAL FUND ADVISORS LP Filed SC 13G/A on KEWAUNEE SCIENTIFIC CORP /DE/, latest Feb 9, 2024 (3 filings since Feb 8, 2022)
  • Peter H. Kamin Filed SC 13D/A on KEWAUNEE SCIENTIFIC CORP /DE/, latest May 16, 2022 (2 filings since Jan 25, 2022)
  • KEWAUNEE SCIENTIFIC CORP /DE/ Dover, Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What KEWAUNEE SCIENTIFIC CORP /DE/ reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$74.4M3 Apr 30, 2026$72.0M3 Apr 30, 2025+3.3%
Accumulated depreciation$52.0M3 Apr 30, 2026$48.8M3 Apr 30, 2025+6.6%
Property and equipment, net$22.4M3 Apr 30, 2026$23.2M3 Apr 30, 2025−3.5%
Operating-lease assets (leased space)$10.8M3 Apr 30, 2026$13.0M3 Apr 30, 2025−16.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$9.9M3 Apr 30, 2026$14.9M3 Apr 30, 2025−33.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$12.5M3 Apr 30, 2026$12.5M3 Apr 30, 20250%
Intangible assets, net (excluding goodwill)$16.3M3 Apr 30, 2026$17.8M3 Apr 30, 2025−8.6%
Accumulated amortization$2.3M3 Apr 30, 2026$769.0K3 Apr 30, 2025+199.9%
Finite-lived intangibles, net$11.4M3 Apr 30, 2026$12.9M11 Apr 30, 2025−11.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$30.5M3 Apr 30, 2026$32.8M3 Apr 30, 2025−7.1%
Raw materials$20.2M3 Apr 30, 2026$23.5M3 Apr 30, 2025−14.1%
Work in process$5.6M3 Apr 30, 2026$3.8M3 Apr 30, 2025+48.4%
Finished goods$4.7M3 Apr 30, 2026$5.5M3 Apr 30, 2025−15.1%

Properties, in its own words

We lease and operate three adjacent manufacturing facilities in Statesville, North Carolina. These facilities also house our corporate offices, as well as sales and marketing, administration, engineering and drafting personnel. On March 24, 2022, we entered into a Sale-Leaseback Arrangement (defined below), pursuant to which we sold, and now lease, our manufacturing and office facilities in Statesville, North Carolina. See Note 7, Sale-Leaseback Financing Transaction, of the Notes to Consolidated Financial Statements included in Item 8 of this Annual Report on Form 10-K for information concerning the Sale-Leaseback Arrangement. In addition, we lease our primary distribution facility and other warehouse facilities in Statesville, North Carolina and an office facility in Charlotte, North Carolina. We also lease office, manufacturing, and warehouse space in Long Lake, Plymouth, and Crystal, Minnesota. In Bangalore, India, we lease and operate a manufacturing facility. International sales and administrative offices are located in Spain, Singapore, India, and Saudi Arabia. We believe our facilities are suitable for their respective uses and are adequate for our current needs.

Item 2 of the 10-K filed Jun 26, 2026.5

Leadership

Who has led KEWAUNEE SCIENTIFIC CORP /DE/, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. William A. Shumaker2007–2013
  2. David M. Rausch2013–2018
  3. Thomas David Hull Iii.2019–now

President

  1. William A. Shumaker2007–2011
  2. David M. Rausch2012–2018
  3. Thomas David Hull Iii.2019–now

Chief financial officer

  1. David Michael Parker2008–2015
  2. Thomas David Hull Iii.2015–2018
  3. Donald T. Gardner Iii.2019–now

Chief operating officer

  1. David M. Rausch2012–2013
2010201520202025
Board members and other officers (26)

Timeline

  1. Sep 9, 20268-K Results of operations46
  2. Aug 27, 20268-K Shareholder vote47
  3. Aug 26, 20268-K Regulation FD disclosure48
  4. Aug 25, 20268-K Other events49
  5. Jun 23, 20268-K Results of operations50
  6. Jun 10, 20268-K Other events51
  7. Mar 11, 20268-K Results of operations52
  8. Feb 25, 20268-K Other events53
  9. Dec 10, 20258-K Results of operations54
  10. Dec 4, 20258-K Entered a material agreement; Ended a material agreement; New debt or obligation55
  11. Nov 26, 20258-K Other events56
  12. Sep 11, 20258-K Executive or director change; Bylaws or fiscal year changed57
  13. Jun 21, 2019New chief executive Thomas David Hull Iii. becomes CEO16
  14. Jul 10, 2013New chief executive David M. Rausch becomes CEO17
  15. Mar 12, 2007New chief executive William A. Shumaker becomes CEO18

Calendar

Coming up

  1. Dec 9, 2026Reports results for the quarter ending Oct/202658

When it reported results

  1. Sep 9, 2026Reported quarterly or annual results46
  2. Jun 23, 2026Reported quarterly or annual results50
  3. Mar 11, 2026Reported quarterly or annual results52
  4. Dec 10, 2025Reported quarterly or annual results54
  5. Sep 10, 2025Reported quarterly or annual results59
  6. Jun 26, 2025Reported quarterly or annual results60
  7. Mar 12, 2025Reported quarterly or annual results61
  8. Dec 11, 2024Reported quarterly or annual results62

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

285 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 58 major events, 141 insider forms, 16 large holders, 50 other. The latest 20:

  1. Sep 11, 202610-Q EDGAR
  2. Sep 9, 20268-K EDGAR
  3. Aug 27, 20268-K EDGAR
  4. Aug 26, 20268-K EDGAR
  5. Aug 25, 20268-K EDGAR
  6. Jul 7, 2026ARS EDGAR
  7. Jul 7, 2026DEFA14A EDGAR
  8. Jul 7, 2026DEF 14A EDGAR
  9. Jul 2, 20264 EDGAR
  10. Jul 2, 20264 EDGAR
  11. Jul 2, 20264 EDGAR
  12. Jul 2, 20264 EDGAR
  13. Jul 2, 20264 EDGAR
  14. Jul 2, 20264 EDGAR
  15. Jun 29, 2026SCHEDULE 13G/A EDGAR
  16. Jun 26, 202610-K EDGAR
  17. Jun 25, 20264 EDGAR
  18. Jun 25, 20264 EDGAR
  19. Jun 25, 20264 EDGAR
  20. Jun 25, 20264 EDGAR

The 285 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

58 open-market trades by officers, directors and large owners since October 2021: 9 buys and 49 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 7, 2026HULL THOMAS DAVID IIIPresident & CEOSale2,177$37.50$81.6KForm 4
Jan 6, 2026Gardner Donald T. IIIChief Financial OfficerSale2,000$37.57$75.1KForm 4
Dec 31, 2025HULL THOMAS DAVID IIIPresident & CEOSale629$37.66$23.7KForm 4
Dec 30, 2025HULL THOMAS DAVID IIIPresident & CEOSale29$38.00$1.1KForm 4
Dec 29, 2025HULL THOMAS DAVID IIIPresident & CEOSale884$38.01$33.6KForm 4
Dec 22, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$39.00$39.0KForm 4
Dec 17, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$39.00$39.0KForm 4
Oct 9, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$42.76$128.3KForm 4
Oct 2, 2025Phillips Elizabeth DSVP, People & CultureSale6,880$43.20$297.2KForm 4
Oct 1, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$43.09$43.1KForm 4
Sep 29, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,854$43.42$80.5KForm 4
Sep 24, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$43.62$43.6KForm 4
Sep 23, 2025HULL THOMAS DAVID IIIPresident & CEOSale721$44.00$31.7KForm 4
Sep 19, 2025HULL THOMAS DAVID IIIPresident & CEOSale773$45.34$35.0KForm 4
Sep 18, 2025HULL THOMAS DAVID IIIPresident & CEOSale652$46.00$30.0KForm 4
Jul 24, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$58.59$175.8KForm 4
Apr 14, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,844$32.44$59.8KForm 4
Apr 10, 2025Gardner Donald T. IIIChief Financial OfficerSale1,000$35.18$35.2KForm 4
Apr 9, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$37.75$113.2KForm 4
Apr 4, 2025GEHL KEITH MDirectorBuy1,000$35.00$35.0KForm 4

All 58 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2026Thomas D. Hull IIIPresident and Chief Executive Officer$526.2K$2.0M68
2026Donald T. Gardner IIIVice President Finance and Chief Financial Officer$393.6K$970.4K68
2026Douglas BatdorffVice President of Manufacturing Operations$290.9K$619.8K68
2025Thomas D. Hull IIIPresident and Chief Executive Officer$485.5K$1.8M68
2025Donald T. Gardner IIIVice President Finance and Chief Financial Officer$357.0K$1.1M68
2025Douglas BatdorffVice President of Manufacturing Operations$257.3K$589.8K68

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 32. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Northern Trust Corp238,111$8.5M0.0%−7,853
Dimensional Fund Advisors LP175,042$6.2M0.0%−2,297
Minerva Advisors LLC149,410$5.3M3.4%+12,705
Vanguard Capital Management LLC110,051$3.9M0.0%−2,462
Punch & Associates Investment Management, Inc.105,545$3.7M0.2%+4,843
Renaissance Technologies LLC95,311$3.4M0.0%−3,200
De Lisle Partners LLP52,626$1.9M0.2%No change
Royce & Associates LP49,700$1.8M0.0%+1,700
American Century Companies Inc49,530$1.8M0.0%−21
Geode Capital Management, LLC24,931$885.8K0.0%+452
Mink Brook Asset Management LLC21,447$761.8K0.3%No change
Northeast Investment Management20,000$710.4K0.0%No change
Morgan Stanley16,828$597.7K0.0%−3,106
Vanguard Fiduciary Trust Co13,172$467.9K0.0%+88
Wealth Enhancement Advisory Services, LLC12,694$464.5K0.0%No change
BlackRock, Inc.11,978$425.5K0.0%+2,054
Bridgeway Capital Management, LLC11,815$419.7K0.0%No change
State Street Corp10,034$356.4K0.0%No change
Verdad Advisers, LP10,000$355.2K0.3%New
LPL Financial LLC8,000$284.2K0.0%No change
Arrowstreet Capital, Limited Partnership6,617$235.0K0.0%No change
IFP Advisors, Inc810$28.8K0.0%+225
Vanguard Global Advisers, LLC800$28.4K0.0%No change
Royal Bank Of Canada800$28.0K0.0%+400
Barclays PLC680$24.2K0.0%−1,457

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How KEWAUNEE SCIENTIFIC CORP /DE/ is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARKEWAUNEE SCIENTIFIC CORP /DE/1
  • CIK0000055529
  • Employer ID (EIN)38-07155625
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
  • Incorporated inDelaware5
  • Fiscal year endsApril 301
  • Industry code (SIC)3821 Laboratory Apparatus & Furniture1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address2700 W Front St, Statesville, NC 286771
  • Mailing addressP O Box 1842, Statesville, NC 28687-18421
  • Phone70487372021
  • Shares outstanding2,895,347 as of Sep 8, 202614
  • Public float$70.1M as of Oct 31, 20255
  • AuditorForvis Mazars, LLP, Raleigh, NC PCAOB ID 686; no auditor attestation of internal control over financial reporting5
  • On EDGAR sinceMar 17, 19951
  • Filings1,081 in all: 4 (528), 8-K (206), 10-Q (95), SC 13G/A (48), DEF 14A (32), 10-K (30), 144 (30), 3 (21)1
    All 28 form types

    SC 13G (13), SD (12), 5 (10), ARS (8), DEFA14A (8), S-8 (7), SC 13D (5), SC 13D/A (5), 10-Q/A (4), UPLOAD (4), 10-K405 (2), 4/A (2), 8-K/A (2), CORRESP (2), SCHEDULE 13G/A (2), 10-K405/A (1), ARS/A (1), NO ACT (1), NT 10-Q (1), SCHEDULE 13D/A (1)

  • Latest filingsAnnual report (10-K) Jun 26, 2026
    Quarterly report (10-Q) Sep 11, 2026
    Proxy statement (DEF 14A) Jul 7, 2026
    Latest 8-K (8-K) Sep 9, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock $2.50 par valueKEQUNASDAQ Global Market

From the cover page of the 10-K filed Jun 26, 2026 (Section 12(b) of the Exchange Act).5

Risk factors and legal proceedings

The risks KEWAUNEE SCIENTIFIC CORP /DE/ names in Item 1A of its 10-K filed Jun 26, 2026: 26 risks under these headings, as written.5

  • Risks Specific to our Company
  • If we lose a large customer, our sales and profits would decline.
  • We rely on the talents and efforts of key management and our Associates. If we are unable to retain or motivate key personnel, hire qualified personnel, or maintain and continue to adapt our corporate culture, we may not be able to grow or operate effectively.
  • We cannot guarantee that our share repurchase program will enhance long-term stockholder value, or that it will successfully mitigate the dilutive effect of employee equity awards.
  • Internal controls over financial reporting may not be effective at preventing or detecting material misstatements.
  • Goodwill and other acquired intangible assets could become impaired and adversely affect our future operating results.
  • Risks Related to Operations
  • Sales to customers outside the United States or with international operations expose us to risks inherent in international sales.
  • Our future growth may depend on our ability to penetrate new international markets.
  • If we fail to compete effectively, our revenue and profit margins could decline.
  • An increase in the price of raw materials could negatively affect our sales and profits.
  • Events outside our control may affect our operating results.
The other 16 risks
  • We face numerous manufacturing and supply chain risks. In addition, our reliance upon sole or limited sources of supply for certain materials, components, and services could cause production interruptions, delays and inefficiencies.
  • Changes in the U.S. political or regulatory environment could affect the availability of government funding, which could negatively impact our business.
  • Disruptions in the financial markets have historically created, and may continue to create, uncertainty in economic conditions that may adversely affect our customers and our business.
  • The effects of geopolitical instability may adversely affect us and heighten significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable.
  • Risks Related to Cybersecurity
  • Our business and reputation are impacted by information technology system failures and network disruptions.
  • Future cybersecurity incidents could expose us to liability and damage our reputation and our business.
  • Our use of new and evolving technologies, such as artificial intelligence (“AI”), could adversely impact our business and financial results.
  • Legal and Regulatory Compliance Risks
  • Our global operations are subject to the laws and regulations of numerous domestic and foreign jurisdictions. Failure to comply with such rules may have a material adverse impact on our business and results of operations.
  • Changes in U.S. trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business and results of operations.
  • Expectations related to environmental, social, and governance ("ESG") considerations could expose us to potential liabilities, increased costs, and reputational harm.
  • General Risks
  • Our stock price is likely to be volatile and could drop.
  • Our stockholders may experience future dilution as a result of future issuances of our shares of common stock.
  • We currently, and may in the future, have assets held at financial institutions that may exceed the insurance coverage offered by the Federal Deposit Insurance Corporation ("FDIC"), the loss of which would have a severe negative effect on our operations and liquidity.
  • The impact of investor concerns on U.S. or international financial systems could impact our ability to obtain favorable financing terms in the future.
  • The impact of future pandemics could adversely affect our business, results of operations, financial condition, and liquidity.
  • We may pursue strategic acquisitions from time to time, in which case we would be subject to the general risks associated with acquisitions.

Legal proceedings

From time to time, we are involved in disputes and litigation relating to claims arising out of our operations in the ordinary course of business. Further, we are periodically subject to government audits and inspections. We believe that any such matters presently pending will not, individually or in the aggregate, have a material adverse effect on our results of operations or financial condition.

The opening of Item 3, Legal Proceedings.5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
    SEC EDGAROther events
  50. 50
  51. 51
    SEC EDGAROther events
  52. 52
  53. 53
    SEC EDGAROther events
  54. 54
  55. 55
  56. 56
    SEC EDGAROther events
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68